Adaptive Biotechnologies financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

어댑티브 바이오테크놀로지스NASDAQ:ADPT · Nasdaq · Healthcare

$28.35+3.58%

2026-10-02 close

Adaptive Biotechnologies's published financial data is dated 2026-10-04. 2024 revenue was $179M. 2024 operating profit was −$163M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy